𝔖 Bobbio Scriptorium

✦ LIBER ✦

Titration of HCTZ to 50 mg Daily in Individuals With Stage 2 Systolic Hypertension Pretreated With an Angiotensin Receptor Blocker

✍ Scribed by Joseph L. Izzo Jr; Joel M. Neutel; ; Robert Dubiel; Findlay Walker; Study Investigators

Book ID: 115306433
Publisher: Le Jacq Communications, Inc.
Year: 2007
Tongue: English
Weight: 724 KB
Volume: 9
Category: Article
ISSN: 1524-6175
DOI: 10.1111/j.1524-6175.2007.05714.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination Angiotensin-Receptor Blocker

Combination Angiotensin-Receptor Blocker (ARB)/Calcium Channel Blocker With HCTZ vs the Maximal Recommended Dose of an ARB With HCTZ in Patients With Stage 2 Hypertension: The Exforge As Compared to Losartan Treatment in Stage 2 Systolic Hypertension (EXALT) Study

✍ Richard F. Wright; Daniel Duprez; Das Purkayastha; Rita Samuel; Keith C. Ferdina 📂 Article 📅 2011 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 253 KB

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB